ON-DEMAND WEBINARS

In this webinar, panelists discuss how connecting sources of real world data (RWD) to clinical trial enables many benefits, including the ability to supplement data for patients lost to follow up and augment trial data to help explain non-responders and adverse events.

An expert panel explores how the industry leverages digital innovation to manage immunotherapy risks and critical next steps toward deploying scalable, technology-driven CRS monitoring solutions.

This webinar will explore the RWE/RWD landscape and focus on those situations in which a prospective observational study or registry presents a more optimal solution.

With the FDA stating last fall that the “patient’s voice” is key to understanding real-world-impacts, eCOAs and ePROs are becoming quintessential tools for cancer trials.

ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS